Provided by Tiger Trade Technology Pte. Ltd.

BioVie Inc

1.56
+0.10006.85%
Post-market: 1.600.0400+2.56%19:54 EDT
Volume:147.34K
Turnover:223.16K
Market Cap:11.66M
PE:-0.30
High:1.57
Open:1.49
Low:1.47
Close:1.46
52wk High:13.20
52wk Low:1.06
Shares:7.48M
Float Shares:7.44M
Volume Ratio:2.69
T/O Rate:1.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1345
EPS(LYR):-12.1239
ROE:-80.74%
ROA:-47.20%
PB:0.61
PE(LYR):-0.13

Loading ...

BioVie SUNRISE-PD bezisterim abstract accepted for presentation at 2026 AAN meeting

Reuters
·
Apr 14

BioVie publishes corporate presentation on bezisterim pipeline catalysts in Parkinson’s, Long Covid

Reuters
·
Apr 02

BioVie to present SUNRISE-PD bezisterim poster at AD/PD 2026

Reuters
·
Mar 12

BioVie Announces Abstract Accepted for Presentation at AD/PD 2026

GlobeNewswire
·
Mar 12

BioVie to Host Live Investor Webinar and Q&A Session with CEO Cuong Do

Reuters
·
Feb 23

Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4

GlobeNewswire
·
Feb 23

BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting

GlobeNewswire
·
Feb 12

BRIEF-Option Therapeutics Files For IPO Of 2.3 Million Shares Of Common Stock - SEC Filing

Reuters
·
Jan 26

Option Therapeutics Inc Says Thinkequity Is the Underwriter to IPO

THOMSON REUTERS
·
Jan 26

BioVie Inc. unveils new data on bezisterim's potential in Parkinson's and Alzheimer's therapies

Reuters
·
Jan 11

BioVie Completes Enrollment for Phase 2 SUNRISE-PD Trial Testing Bezisterim in Early Parkinson’s Disease

Reuters
·
Jan 08

BioVie Inc - Topline Results From Sunrise-Pd Trial Expected in 1H 2026

THOMSON REUTERS
·
Jan 08

BioVie Completes Enrollment in Phase 2 Sunrise-Pd Trial in Early Parkinson’s Disease

THOMSON REUTERS
·
Jan 08

Halozyme Therapeutics Elects Jim Lang to Board of Directors

Reuters
·
Dec 09, 2025

Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9

GlobeNewswire
·
Nov 19, 2025

BioVie Inc. Files Initial Statement of Beneficial Ownership for Director Kameel D. Farag

Reuters
·
Oct 28, 2025

BioVie Inc. Files Initial Beneficial Ownership Statement for Director Amy Suzon Chappell

Reuters
·
Oct 28, 2025